News2019-07-09T13:26:36+02:00

NEWS

Takeda Completes Acquisition of Shire

January 10, 2019|HAEi News|

Takeda Pharmaceutical Company Limited has completed its acquisition of Shire plc, becoming a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan. Takeda now has an attractive, expanded geographic footprint and leading position in Japan and [...]

“Global Perspectives” #4/2018 out now

December 21, 2018|HAEi News|

Dear HAE friends, With this fourth and final issue of the HAEi magazine Global Perspectives, we send you our sincerest best wishes for a festive holiday season and a healthy 2019. In this issue of our magazine you will, [...]

Enlarged Phase 2 Trial on Track

December 14, 2018|HAEi News|

KalVista Pharmaceuticals, Inc. has provided an operational update and released financial results for the fiscal second quarter ended October 31, 2018. CEO Andrew Crockett says: “We are still on track with our robust Phase 2 study [...]

Oral formulation rapidly absorbed

November 16, 2018|HAEi News|

BioCryst Pharmaceuticals, Inc. presents data showing that an oral formulation of BCX7353 was rapidly absorbed and exhibited a long half-life, two important characteristics of desired new acute treatments for HAE attacks. In the trial, the pharmacokinetic (PK) and [...]

Health Canada authorizes TAKHZYRO

September 20, 2018|HAEi News|

Shire plc and Shire Pharma Canada ULC (Shire Canada) announces that following priority review, Health Canada has authorized TAKHZYRO (lanadelumab injection) for routine prevention of attacks of HAE in adolescents and adults (12 years of [...]

Load More Posts

Stay Tuned

Be the first to know what’s going on in the world of HAE

Upcoming events


Jul 25, 2019 - Jul 26, 2019
HAE Global Youngsters Advocacy Workshop


Jul 25, 2019 - Jul 28, 2019
US HAEA Summit

United States
Jul 28, 2019
HAE IN-MOTION 5K walk/run

United States
Sep 7, 2019
HAE IN-MOTION Awareness Walk

>> View full event calendar

Check out our latest newsletters

HAE related topics that might interest you

Global Access Program

Helping to change the lives of patients with hereditary angioedema (HAE) with a medication access program

Global Perspectives

Magazine with timely information on the issues, activities, and events that are relevant to the global HAE community

HAEi Connect Member database

Free, secure online membership database and communications platform for HAEi’s member organizations

Regional Patient Advocates

Constantly strive to improve the situation for HAE friends all over the world – no matter how they are organized

Stay tuned – sign up for our newsletter

BE THE FIRST TO KNOW ABOUT HAE NEWS, TREATMENTS, EVENTS AND RELATED TOPICS

Click here to sign up

HAE Global Conference 2018

This 4th HAE conference was record breaking: A total of 736 patients and care givers participated from no less than 57 countries

HAEi hosted websites

Hosting of your national website or help for you to create a new website – naturally all in your native language